Aplastic anemia resulting from the use of carbonic anhydrase inhibitors

Nathaniel Wisch, Frederic I. Fischbein, Richard Siegel, Joseph L. Glass, Irving Leopold

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

Aplastic anemia followed the use of acetazolamide in a 72-year-old man and the use of methazolamide in a 71-year-old woman. The mechanism by which these drugs suppress bone marrow function is unknown and in fact the etiologic role of these drugs causing aplasia of the bone marrow is presumptive. Periodic blood counts are important to detect early signs of marrow suppression when these drugs are administered.

Original languageEnglish
Pages (from-to)130-132
Number of pages3
JournalAmerican Journal of Ophthalmology
Volume75
Issue number1
DOIs
StatePublished - Jan 1973
Externally publishedYes

Fingerprint

Dive into the research topics of 'Aplastic anemia resulting from the use of carbonic anhydrase inhibitors'. Together they form a unique fingerprint.

Cite this